For Parenteral Use
DEMEROL (meperidine hydrochloride injection) is clear and colorless.
DEMEROL (meperidine hydrochloride injection) is supplied as a sterile solution in a multiple-dose vial, single-dose Carpuject™ cartridges for use ONLY with the Carpuject™ Holders and NexJect™ prefilled syringes for subcutaneous, intramuscular, and intravenous administration, and available as follows:
| Unit of Sale | Concentration (per total volume) |
|---|---|
NDC 0409-1181-30 | 1,500 mg/30 mL |
NDC 0409-1176-30 | 25 mg/mL |
NDC 0409-1178-30 | 50 mg/mL |
NDC 0409-1179-30 | 75 mg/mL |
NDC 0409-1180-69 | 100 mg/mL |
NDC 0409-1362-01 | 25 mg/mL |
NDC 0409-1418-01 | 50 mg/mL |
Carpuject™ Single-dose cartridges are packaged in a Slim-Pak tamper detection package.
Note that a needle is not included with Carpuject™ Single-dose cartridges and Nexject™ Single-dose Prefilled Syringes.
Carpuject and NexJectTM Single-dose products: Discard unused portion.
Multiple-dose vials: Discard unused portion after 28 days.
For Parenteral Use
DEMEROL (meperidine hydrochloride injection) is clear and colorless.
DEMEROL (meperidine hydrochloride injection) is supplied as a sterile solution in a multiple-dose vial, single-dose Carpuject™ cartridges for use ONLY with the Carpuject™ Holders and NexJect™ prefilled syringes for subcutaneous, intramuscular, and intravenous administration, and available as follows:
| Unit of Sale | Concentration (per total volume) |
|---|---|
NDC 0409-1181-30 | 1,500 mg/30 mL |
NDC 0409-1176-30 | 25 mg/mL |
NDC 0409-1178-30 | 50 mg/mL |
NDC 0409-1179-30 | 75 mg/mL |
NDC 0409-1180-69 | 100 mg/mL |
NDC 0409-1362-01 | 25 mg/mL |
NDC 0409-1418-01 | 50 mg/mL |
Carpuject™ Single-dose cartridges are packaged in a Slim-Pak tamper detection package.
Note that a needle is not included with Carpuject™ Single-dose cartridges and Nexject™ Single-dose Prefilled Syringes.
Carpuject and NexJectTM Single-dose products: Discard unused portion.
Multiple-dose vials: Discard unused portion after 28 days.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.